Fusarium R1-UV-4-3a of high-yield cyclic phenolphthalein compound and application of fusarium R1-UV-4-3a

Fusarium R1-UV-4-3a with high SA yield was obtained by ultraviolet mutagenesis screening of Fusarium CGMCC NO.17763, and specific culture medium and fermentation conditions were used to solve the problem of low SA yield in the prior art, realizing the realization of the realization of the problem of low SA yield. SA is efficiently produced and industrialized.

CN119020173AActive Publication Date: 2024-11-26ZHEJIANG UNIV OF TECH

Patent Information

Application Number
CN202411331504.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-24
Publication Date
2024-11-26
Estimated Expiration
2044-09-24

AI Technical Summary

Technical Problem

In the prior art, the yield of cyclophenolic ethalin compound SA is relatively low, making it difficult to achieve large-scale production.

Method used

Fusarium CGMCC NO.17763 was used for ultraviolet mutagenesis screening, and high-yield SA Fusarium strain R1-UV-4-3a was obtained, and specific medium composition and fermentation conditions were used, including activation in PDA and PDB medium and Fermentation, ultrasonic extraction and chromatography purification, and increase SA yield.

Benefits of technology

The fermentation titer of SA was increased by about 48%, and the genetic stability of the strain was maintained, making it suitable for the industrial production of compound SA.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0005057076560000011
    Figure BDA0005057076560000011
  • Figure BDA0005057076560000041
    Figure BDA0005057076560000041
  • Figure FDA0005057076550000011
    Figure FDA0005057076550000011
Patent Text Reader

Abstract

The invention discloses fusarium R1-UV-4-3a with high yield of cyclic phenolphthalein compounds and application of the fusarium R1-UV-4-3a. The genetic stability of the fusarium R1-UV-4-3a is good, and the level of producing the cyclic phenolphthalein compounds when the fusarium R1-UV-4-3a is transferred to the sixth generation is equivalent to that of the first generation; meanwhile, the titer of the cyclic phenolphthalein compound in a fermentation product of the strain is increased by about 48% compared with that of the cyclic phenolphthalein compound in a fermentation product of an original strain, and the strain can be applied to industrial production of the cyclic phenolphthalein compound.
Need to check novelty before this filing date? Find Prior Art

Description

(I) Technical field

[0001] The invention relates to Fusarium R1-UV-4-3a with high yield of cyclic phenolphthalein compounds and application thereof. (II) Background technology

[0002] SA is a cyclic phenolphthalein compound, which was first obtained by Cueto et al. in 2000 from the liquid fermentation products (mycelium and fermentation broth) of Fusarium sp. CNL-619, with a yield of about 3 mg / L; in 2023, Park et al. discovered that Fusarium solani f. also produces SA in agar medium, but there is no yield report.

[0003]

[0004] Modern pharmacological studies have shown that SA has significant anti-tumor activity. SA and its analogs can effectively inhibit the growth of pancreatic cancer cell lines and can inhibit the proliferation of bladder cancer cells and colon cancer cells. SA shows potential anti-tumor activity in the treatment of different types of cancer, providing a promising direction for the development of new anti-tumor drugs. Patent application CN115505033A discloses a method for preparing SA, which is as follows: centrifuging the fermentation mixture of Fusarium CGMCC NO.17763, taking the precipitate after centrifugation, adding methanol and performing ultrasonic-assisted extraction. The organic layer is concentrated under reduced pressure to obtain a crude extract, and the crude extract is dissolved in chromatographic methanol and then filtered through a membrane and then SA is prepared using high-performance liquid chromatography. Although the SA yield has been improved to a certain extent after the fermentation conditions of Fusarium CGMCC NO.17763 have been systematically optimized (Fermentation.2024; 10(3):140), it is still difficult to achieve large-scale fermentation preparation.

[0005] Therefore, it is necessary to screen an excellent strain that can produce high SA. (III) Summary of the invention

[0006] The present invention aims to provide a high-SA-yielding Fusarium R1-UV-4-3a and its application, so as to solve the problem that the fermentation titer of the compound SA obtained by the original strain using the traditional fermentation method is low.

[0007] The technical solution adopted by the present invention is:

[0008] The present invention provides a high-SA-producing Fusarium sp. R1-UV-4-3a, which is deposited in China Center for Type Culture Collection with a deposit number of CCTCC NO: M 20241573, a deposit date of July 15, 2024, and an address of Wuhan University, Wuhan, China, with a zip code of 430072. The Fusarium sp. R1-UV-4-3a of the present invention is obtained by ultraviolet mutagenesis screening of Fusarium sp. CGMCC NO.17763.

[0009] The present invention also provides an application of the Fusarium R1-UV-4-3a in producing SA by fermentation.

[0010] Furthermore, the application includes the following steps: (1) inoculating Fusarium R1-UV-4-3a into PDA culture medium, activating and culturing at 30-37°C for 3-5 days, and then inoculating into PDB liquid culture medium, culturing at 30-37°C and 150-200rpm for 60-80 hours to obtain seed liquid; (2) inoculating the seed liquid into a fermentation medium at an inoculum amount of 1-10% by volume, fermenting and culturing at 20-30°C for 10-15 days to obtain a fermentation liquid containing SA, separating and purifying to obtain SA; the fermentation medium is composed of: 20-30 g / L sucrose, 10-20 g / L tryptone, 20-40 mg / L yeast extract, 10-30 g / L sea salt, pH 6.5, the solvent is water, the liquid volume of the fermentation medium is 50% of the container capacity, and sterilizing at 121°C for 20 minutes.

[0011] Furthermore, the PDA culture medium is composed of: 200.0 g / L potato, 20.0 g / L glucose, 15.0-20.0 g / L agar, natural pH, solvent is water, and sterilized at 121° C. for 20 min; the PDB liquid culture medium is composed of: 200.0 g / L potato, 20.0 g / L glucose, natural pH, solvent is water, and sterilized at 121° C. for 20 min.

[0012] Furthermore, in step (1), the temperature of the seed culture is 35° C., the rotation speed is 180 rpm, and the time is 72 h.

[0013] Furthermore, the volume inoculation amount of the seed solution in step (2) is 5%.

[0014] Furthermore, the fermentation medium consists of 22.5 g / L sucrose, 16.5 g / L tryptone, 24 mg / L yeast extract, 20.0 g / L sea salt, pH 6.5, and water as the solvent.

[0015] Furthermore, in step (2), the fermentation culture temperature is 25° C. and the culture is statically cultured for 13 days.

[0016] Compared with the prior art, the beneficial effects of the present invention are mainly reflected in: the present invention provides a high-SA-producing Fusarium strain R1-UV-4-3a, which has good genetic stability, and the level of compound SA produced in the sixth generation is equivalent to that in the first generation; at the same time, the titer of SA in the fermentation product of the strain is increased by about 48% compared with the titer of SA in the fermentation product of the original strain, and can be applied to the industrial production of compound SA. (IV) Description of the drawings

[0017] Figure 1 This is the relationship curve between ultraviolet irradiation time and the lethality of the original strain.

[0018] Figure 2 The morphological differences between the original strain (a) and the mutant strain (b) are shown.

[0019] Figure 3 This is the HPLC analysis chart of the fermentation product of the original strain.

[0020] Figure 4 This is the HPLC analysis spectrum of Fusarium R1-UV-4-3a fermentation products. (V) Specific implementation methods

[0021] The present invention is further described below in conjunction with specific embodiments, but the protection scope of the present invention is not limited thereto:

[0022] In the embodiment of the present invention, the PDA medium is composed of: 200.0g / L potato, 20.0g / L glucose, 15.0-20.0g / L agar, natural pH, water as solvent, and sterilized at 121°C for 20min; the PDB liquid medium is composed of: 200.0g / L potato, 20.0g / L glucose, natural pH, water as solvent, and sterilized at 121°C for 20min.

[0023] The fermentation medium composition is: sucrose 22.5 g / L, tryptone 16.5 g / L, yeast extract 0.024 g / L, sea salt 20.0 g / L, pH 6.5, the solvent is water, the fermentation liquid filling volume is 50% of the container capacity, and it is sterilized at 121°C for 20 minutes.

[0024] Example 1. Mutation and screening of Fusarium strain R1-UV-4-3a

[0025] The Fusarium strain R1-UV-4-3a of the present invention is obtained by using Fusarium CGMCC NO.17763 (disclosed in patent application CN110563740A) as the original strain and undergoing ultraviolet radiation mutagenesis screening, comprising the following steps:

[0026] (1) Inoculate the original strain into PDA medium and culture at 30°C for 3-5 days; add distilled water, scrape off spores with an inoculation loop, and adjust the concentration of the spore suspension to 10 using a hemocytometer. 5 CFU / mL.

[0027] (2) The spore suspension obtained in step (1) was irradiated with ultraviolet light for 0 s, 60 s, 120 s, 180 s, 240 s, and 300 s at an irradiation power of 8 W and an irradiation distance of 10 cm, and then spread on PDA medium and cultured at 30° C. for 3 to 5 days. The effect of different ultraviolet irradiation times on the lethality of the strain was calculated based on the growth of single colonies on the plates with different irradiation times and with the blank as the control. Figure 1 The colony morphology of the mutant strain after mutagenesis is almost the same as that of the original strain ( Figure 2 ), so the colonies on the plates with a lethality rate of more than 80% were selected for subsequent fermentation and yield detection.

[0028] The formula for calculating the fatality rate is:

[0029] Lethality rate = [(1-number of colonies after mutagenesis) / number of colonies before mutagenesis] × 100%

[0030] (3) Select the colonies on the plate with a lethality rate of more than 80% in step (2), and inoculate them into PDB liquid culture medium for seed culture. The culture conditions are 35° C., 180 rpm, and 3 days.

[0031] (4) The seed solution obtained in step (3) was inoculated into a fermentation medium at a volume concentration of 5% for fermentation culture at a culture temperature of 25° C. and allowed to stand for 13 days.

[0032] (5) The fermentation liquid of step (4) was filtered through gauze to collect the bacterial cells. About 25 g of bacterial cells were extracted with 300 mL of methanol by ultrasonic extraction at 480 W for 30 min, and then filtered, the filtrate was retained, and rotary evaporated until there was no liquid. After dissolving with 15 mL of chromatographic methanol, it was filtered using a 0.22 μm organic filter head, and 1 mL of the liquid was taken to detect the change in SA production by HPLC. The strains with significant changes in SA production compared with the original strain were screened by the increase or decrease in peak type and the change in relative area.

[0033] HPLC conditions: Shimadzu liquid phase analyzer LC-20AT, photodiode array UV-visible detector SPD-M40, autosampler SIL-20A, chromatographic column Phenomenex Gemini NX-C18 (4.6 mm×250 mm, 5 μm), injection volume 10 μL, flow rate 1.0 mL / min, column temperature 40°C, detection wavelength 210 nm, mobile phase acetonitrile: water (containing 0.1% formic acid) = 70:30 (v / v), isocratic elution.

[0034] (6) Select the high-SA-producing mutant strain corresponding to the plate colony in step (2) for subculture. After six consecutive generations, select the sixth-generation strain for culture and fermentation, and perform HPLC analysis to screen the mutant strain with stable high SA production.

[0035] The results showed that a high-SA-producing Fusarium mutant was screened and classified as Fusarium sp., with strain number R1-UV-4-3a. It was deposited in the China Type Culture Collection of Wuhan University, No. 299, Bayi Road, Wuchang District, Wuhan City, Hubei Province on July 15, 2024, with the deposit number CCTCC NO:M 20241573.

[0036] Example 2: Stability analysis of SA produced by Fusarium R1-UV-4-3a

[0037] (1) Fusarium R1-UV-4-3a was inoculated into PDA medium and activated and cultured at 30°C for 3 days, and then subcultured to the sixth generation.

[0038] (2) The first and sixth generation strains of step (1) were inoculated into PDB medium respectively, and cultured at 35° C. and 180 rpm for 72 h to obtain seed solution.

[0039] (3) The seed solution from step (2) was inoculated into the fermentation medium at a volume concentration of 5%, and the fermentation was allowed to stand at 25°C for 13 days to obtain a fermentation broth. The SA production was detected by the method described in Example 1, with the original strain as the control, and each strain was repeated 3 times. The results are shown in Table 1. HPLC of the first generation fermentation broth of the original strain is shown in Table Figure 3 HPLC of the first generation fermentation broth of Fusarium R1-UV-4-3a Figure 4 .

[0040] Table 1: SA production of strains

[0041]

[0042] The data in Table 1 show that the yield of compound SA in the fermentation product of the original strain was 126 ± 1.06 mg / L;

[0043] The yield of compound SA in the fermentation product of strain R1-UV-4-3a was 182±1.98 mg / L, which was about 48% higher than that of the original strain, and strain R1-UV-4-3a was genetically stable.

Claims

1. A Fusarium sp. R1-UV-4-3a with high production of cyclic phenolphthalein compounds, deposited in China Center for Type Culture Collection, with a deposit number of CCTCC NO: M 20241573, a deposit date of July 15, 2024, address: Wuhan University, Wuhan, China, Postal Code 430072.

2. Use of the Fusarium R1-UV-4-3a according to claim 1 in fermentation to produce cyclic phenolphthalein compounds.

3. The use according to claim 2, characterized in that The application comprises the following steps: (1) inoculating Fusarium R1-UV-4-3a into PDA culture medium, activating and culturing at 30-37°C for 3-5 days, then inoculating into PDB liquid culture medium, culturing at 30-37°C and 150-200rpm for 60-80 hours to obtain seed liquid; (2) inoculating the seed liquid into fermentation culture medium at an inoculum amount of 1-10% by volume, culturing at 20-30°C for 10-15 days to obtain fermentation liquid containing cyclohexylphthalene compounds, separating and purifying to obtain cyclohexylphthalene compounds; the fermentation culture medium comprises: 20-30 g / L sucrose, 10-20 g / L tryptone, 20-40 mg / L yeast extract, 10-30 g / L sea salt, pH 6.5, the solvent is water, the liquid volume of the fermentation culture medium is 50% of the container capacity, and sterilizing at 121°C for 20 minutes; Cyclic phenolphthalein compounds:

4. The use according to claim 3, characterized in that The PDA culture medium is composed of: 200.0 g / L potato, 20.0 g / L glucose, 15.0-20.0 g / L agar, natural pH, and water as solvent; the PDB liquid culture medium is composed of: 200.0 g / L potato, 20.0 g / L glucose, natural pH, and water as solvent.

5. The use according to claim 3, characterized in that The temperature of the seed culture in step (1) is 35° C., the rotation speed is 180 rpm, and the time is 72 h.

6. The use according to claim 3, characterized in that The volume inoculation amount of the seed solution in step (2) is 5%.

7. The use according to claim 3, characterized in that The fermentation medium comprises: 22.5 g / L sucrose, 16.5 g / L tryptone, 24 mg / L yeast extract, 20.0 g / L sea salt, pH 6.5, and the solvent is water.

8. The use according to claim 3, characterized in that The fermentation temperature in step (2) is 25° C. and the culture is statically cultured for 13 days.

Citation Information

Patent Citations

  • Alpha-pyrone compound, preparation method and applications thereof, and strains

    CN110563740A

  • Cyclic depsipeptide compound as well as preparation method and application thereof

    CN115505033A

  • Novel fusarium fujikuroi and method for producing gibberellins A4 through fermenting fusarium fujikuroi

    CN105524840A

  • Pharmaceutical composition for inhibiting angiogenesis containing cyclic pentadepsipeptide as active ingredient

    CN109689083A

  • Microorganism of fusarium genus producing cyclic pentadepsipeptides

    KR1020100080741A

Cited By

  • Efficient purification method of N-methylensansalvamide in fusarium fermentation product

    CN120271663A